Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot trial of Caelyx in combination with Taxotere in advanced breast cancer
2005-001499-10Phase 2Active
- Sponsor
- Dr. José Ramón Mel Lorenzo
- Start
- Apr 2006
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of pegylated liposomal doxorubicin and docetaxel in breast cancer, sponsored by Dr. José Ramón Mel Lorenzo. Primary endpoint: Overall response rate. Started Apr 2006; status: active.
02
Drugs
pegylated liposomal doxorubicindocetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2005-001499-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001499-10.